ABHD5 and myopathy: In the absence of functional ABHD5, TAGs accumulate to pathophysiological levels across virtually every cell type, leading to a wide range of clinical symptoms, including hepatomegaly, myopathy, developmental delays, and neurological impairments, such as sensorineural hearing loss or mental retardation (1, 2, 3, 6).